Tests ultrasound cavitation for belly fat and insulin resistance in women
Tests ultrasound cavitation on insulin resistance in women with abdominal central obesity.
Plain-language title generated from the registry record
Registry title: Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female
Key facts
- Where
- Giza, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 25 and 40 years old?
Source: NCT06729203, who can take part
Where in Egypt
- Cairo UniversityGiza, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Cairo University
- Trial code
- NCT06729203
- Record updated
- 11 December 2024
- Original description
The purpose of this study was to investigate the effect of ultrasound cavitation on insulin resistance, HbA1c and skin fold in patients with abdominal central obesity.Read full original descriptionShow less
Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female
The purpose of this study was to investigate the effect of ultrasound cavitation on insulin resistance, HbA1c and skin fold in patients with abdominal central obesity.
Inclusion: Female subjects with central obesity; Female participants aged between 25 to 40 years; Body Mass Index (BMI) ranged from 30 to 35 kg/m2 as high BMI indicates more obesity and central obesity; Waist circumference greater than 88 cm, indicative of abdominal obesity; Diagnosed with insulin resistance (HOMA-IR > 2.9); Sedentary lifestyle, defined as engaging in less than 150 minutes of moderate-intensity physical activity per week; Willingness to provide informed consent and comply with study procedures.
Exclusion: • Subjects diagnosed with DM (HbA1c more than 6.5%); History of metabolic disorders such as type 1 diabetes or thyroid disorders; Subjects with BMI less than 30 kg/m2; Subjects diagnosed with heart disease, liver as well as kidney diseases; Subjects who take oral contraceptives; Subjects with gestational Diabetes; Pregnant or breastfeeding women were excluded from the study; Use of weight-loss medications or supplements within the past six months; Previous surgical procedures for weight loss or body contouring; Contraindications to ultrasound therapy (e.g., metal implants in the abdomen, active skin infections); Participation in another clinical trial within the last three months.